ChartRow logo
Data provided bySource: Twelve Data
HALO
$95.97-0.55%
as of close, Nov 17, 2026
☾ AH $95.97 -0.55%
Share this page

Halozyme Therapeutics Inc. trailing returns

Halozyme Therapeutics Inc.'s 10-year return is +22.1% a year (CAGR) (+639.4% cumulative). How Halozyme Therapeutics Inc. (HALO) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through November 17, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

Data provided bySource: Twelve Data

To 2026-11-17. Price return + dividends = total return. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
Cumulative
1 day-0.5%+0.0%-0.5%—
5 days-6.8%+0.0%-6.8%-6.8%Nov 17
1 month-21.2%+0.0%-21.2%-26.8%Nov 17
YTD+42.6%+0.0%+42.6%-26.8%Nov 17
Per year (CAGR)
1 year+36.0%+0.0%+36.0% CAGR-26.8%Nov 2026
5 years+21.1%+0.0%+21.1% CAGR+160.6% total-49.1%May 2023
10 years+22.1%+0.0%+22.1% CAGR+639.4% total-49.1%May 2023
20 years+19.6%+0.0%+19.6% CAGR35.8x total-74.3%Dec 2008
Since 2004+14.7%+0.0%+14.7% CAGR22.6x total-74.3%Dec 2008

Growth of HALO#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+21.1%/year · +160.6%
  • 10 years+22.1%/year · +639.4%
  • 20 years+19.6%/year · +3481.0%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-11-17). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in HALO's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Halozyme Therapeutics Inc.'s 10-year return?
Over the last 10 years, Halozyme Therapeutics Inc. (HALO) returned about +22.1% a year annualized (+639.4% cumulative total return).
What is Halozyme Therapeutics Inc.'s 20-year annualized return?
Over the last 20 years, Halozyme Therapeutics Inc. (HALO) compounded at about +19.6% a year (+3481.0% cumulative).
What is Halozyme Therapeutics Inc.'s return since inception?
Since 2004, Halozyme Therapeutics Inc. (HALO) has compounded at about +14.7% a year — +2158.1% in total.

More on Halozyme Therapeutics Inc.